I agree that this site is using cookies. You can find further informations here.
X
Peñalver, Francisco Javier
225  results:
Search for persons X
?
1

Risk Factors and Mortality of COVID-19 in Patients With Lym..:

Regalado-Artamendi, Isabel ; Jiménez-Ubieto, Ana ; Hernández-Rivas, José Ángel...
HemaSphere.  5 (2021)  3 - p. e538 , 2021
Link: https://doi.org/10.1097/..
 
?
2

Prognostic utility of serum free light chain ratios and hea..:

Lopez-Anglada, Lucia ; Cueto-Felgueroso, Cecilia ; Rosiñol, Laura...
PLOS ONE.  13 (2018)  9 - p. e0203392 , 2018
Link: https://doi.org/10.1371/..
 
?
3

Recommendations on the clinical use of bendamustine in lymp..:

Peñalver, Francisco Javier ; Delgado, Julio ; Loscertales, Javier...
European Journal of Haematology.  96 (2015)  5 - p. 532-540 , 2015
Link: https://doi.org/10.1111/..
 
?
4

Evaluation of Clinical and Biological Prognostic Factors in..:

Panizo, Carlos ; Rodríguez, Anny Jaramillo ; Gutiérrez, Gonzalo...
Clinical Lymphoma Myeloma and Leukemia.  15 (2015)  7 - p. 398-403 , 2015
Link: https://doi.org/10.1016/..
 
?
5

Patterns of relapse and outcome of elderly multiple myeloma..:

Lopez, Aurelio ; Mateos, Maria-Victoria ; Oriol, Albert...
Leukemia Research Reports.  4 (2015)  2 - p. 64-69 , 2015
Link: https://doi.org/10.1016/..
 
?
6

Rituximab is an effective and safe therapeutic alternative ..:

Peñalver, Francisco Javier ; Alvarez-Larrán, Alberto ; Díez-Martin, Jose Luis...
Annals of Hematology.  89 (2010)  11 - p. 1073-1080 , 2010
Link: https://doi.org/10.1007/..
 
?
7

Rituximab in the management of chronic immune thrombocytope..:

On behalf of the Multi-institutional Retrospective Spanish Study on the use of rituximab in refractory ITP ; Peñalver, Francisco Javier ; Jiménez-Yuste, Victor...
Annals of Hematology.  85 (2006)  6 - p. 400-406 , 2006
Link: https://doi.org/10.1007/..
 
?
8

Bortezomib, melphalan, and prednisone versus bortezomib, th..:

Mateos, María-Victoria ; Oriol, Albert ; Martínez-López, Joaquín...
The Lancet Oncology.  11 (2010)  10 - p. 934-941 , 2010
Link: https://doi.org/10.1016/..
 
?
9

Rituximab is an effective and safe therapeutic alternative ..:

Peñalver, Francisco Javier ; Alvarez-Larrán, Alberto ; Díez-Martin, Jose Luis...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00277-010-0997-y.  , 2010
Link: https://hal.archives-ouv..
 
?
10

Persistence and Waning of Natural SARS-CoV-2 Antibodies Ove..:

Varona, Jose F. ; Muñiz, Javier ; Balboa-Barreiro, Vanesa...
Journal of General Internal Medicine.  37 (2022)  10 - p. 2614-2616 , 2022
Link: https://doi.org/10.1007/..
 
?
11

Genomic mutation profile in progressive chronic lymphocytic..:

González-Rincón, Julia ; Garcia-Vela, José A. ; Gómez, Sagrario...
PLOS ONE.  16 (2021)  9 - p. e0257353 , 2021
Link: https://doi.org/10.1371/..
 
?
12

Management of Persistent SARS-CoV-2 Infection in Patients w..:

Martínez-Barranco, Pilar ; García-Roa, María ; Trelles-Martínez, Roberto...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059018/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
13

R-COMP versus R-CHOP as first-line therapy for diffuse larg..:

Sancho, Juan-Manuel ; Fernández-Alvarez, Rubén ; Gual-Capllonch, Francisco...
Cancer Medicine.  , 2021
Link: https://ddd.uab.cat/reco..
 
?
14

High prognostic value of measurable residual disease detect..:

García-Marco, José A ; Jiménez, Javier López ; Recasens, Valle...
http://hdl.handle.net/10668/13733.  , 2019
Link: http://hdl.handle.net/10..
 
?
15

Response-adapted treatment with rituximab, bendamustine, mi..:

Peñalver, Francisco-Javier ; Márquez, José-Antonio ; Durán, Soledad...
http://hdl.handle.net/10668/14572.  , 2019
Link: http://hdl.handle.net/10..
 
1-15